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A Pathophysiological Approach to
the Treatment of Infectious Diarrhea
in the Neonatal Calf and Pig
by Helen M. Berschneider, DVM*
Robert A. Argenzio, PhD**
INTRODUCTION
The most important cause of economic loss
in the beef and pork industries is infectious
neonatal diarrhea. Although diarrhea of man
and anin1als has been studied for hundreds of
years very little has been learned about how to
control it. In the last 100 years the major ad-
vancement in the treatment of diarrhea has
been the use of oral glucose and electrolyte
solutions for the replacement of fluid 10sses21 A
variety of chemotherapeutic agents have been
developed and employed in an attempt to con-
trol the causative agents and cellular mecha-
nisms which lead to diarrhea. The ever grow-
ing mass of conflicting data and new informa-
tion makes the choice of a therapeutic regimen
difficult indeed. This paper is an atten1pt to
review and summarize current information
regarding the major etiologies, pathophysiol-
ogy and methods of treatment of infectious
diarrhea in the neonatal calf and pig.
ETIOLOGIES
A variety of factors contribute to the
pathogenesis of neonatal diarrhea. Under field
conditions it is unlikely that any particular
case of diarrhea can be said to have a single
cause. However, in many cases a major in-
citing cause may be determined with other
contributing factors being identified as sec-
ondary. Some researchers and practitioners
contend that an etiologic diagnosis of diarrhea
is unnecessary because the effect on the victim
is essentially the same regardless of the cause.
While this may be true for affected animals,
diagnosis is imperative for the prevention of
future outbreaks from the same cause.
*Dr. Berschneider is a 1982 graduate of Iowa State
University College of Veterinary Medicine.
**Dr. Argenzio is a Professor in the Department of
Anatomy, Physiology and Radiology, College of Vet-
erinary Medicine, North Carolina State University,
Raleigh, North Carolina.
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Factors resulting in diarrhea in baby
animals may be either infectious or noninfec-
tious. Since the major economic loss is due to
infectious etiologies only those will be dis-
cussed here. Although vast amounts ofknowl-
edge have been gained about the disease caus-
ing mechanisms of infectious agents the
methods of control are still elusive. Infectious
diarrhea can be divided into three n1ajor
etiologic classifications: viral, bacterial and
protozoal. The first two are being considered
the most significant in the neonate. Two field
studies have shown Eschericia coli to be the ma-
jor cause of neonatal diarrhea in the calf (Fig.
1). 16 No current data are available for the pig.
Viral causes of enteritis are a growing con-
cern in the beef and pork industries. Cor-
onavirus and rotavirus are the major enteric
viruses encountered. Coronavirus is the
etiological agent for transmissible gastro-
enteritis (TGE) of swine. Rotavirus, while
causing a less severe lesion, is still economical-
ly important in both swine and cattle. Par-
vovirus is important in dogs and cats but does
not seem to be a major enteric pathogen of
food animals. The sInaller viruses, such as the
astroviruses and calicivirus-like agents have
been implicated in neonatal diarrhea but their
pathogenesis and significance is still being
worked out. Although BVD is an important
diarrheal disease in cattle it is primarily a
disease of older calves and adults and not a
significant problem in the neonate.
Acute bacterial enteric disease is a major
cause of death and economic loss in the food
animal industry. As noted above, E. coli stands
out as the most important cause of neonatal
diarrhea. This statistic may, in part, be
skewed by the fact that E. coli is the easiest of
the pathogens to isolate and identify. Many
cases of E. coli diarrhea may have unidentified
primary pathogens which are never suspected
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Fig. 1. Calf losses attributed to neonatal disease agents.
possibly because they are never sought. Other
bacterial agents important in neonatal diar-
rhea are Salmonella spp. and Clostridium per-
fringens type D in pigs. Mixed infections of
various viruses and/or bacteria are commonly
encountered.
Two types of pathogenic E. coli are found in
enteric disease: an invasive type which
penetrates the mucosa and may cause septice-
mia and endotoxic shock; and a noninvasive
enterotoxigenic type which attaches to the
mucosal epithelial cells and elaborates a toxin
which alters the metabolic processes of these
cells without altering their histological ap-
pearance. The pathophysiology of enterotox-
igenic E. coli will be covered in more detail
below.
Salmonella is an invasive pathogen, penetrat-
ing the intestinal mucosa where it proliferates
and produces toxins. These toxins may cause
local necrosis or, if high enough concentra-
tions occur in the blood steam, endotoxic
shock may result. Clostridium perfringens is a
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noninvasive exotoxin producer which attaches
to the villi in much the same manner as the
enterotoxigenic E. coli. The toxins produced
by the Clostridial organisms cause necrosis of
the mucosa resulting in hemorrhage and
bloody diarrhea. Peracute cases of Clostridial
enteritis may result in sudden death before the
development of any other clinical signs.
The last major group of enteric pathogens to
be considered are the protozoans. Coccidiosis
is the best known of the protozoal enteric
diseases. It is a neonatal problem primarily in
the pig with cattle being affected only after
three weeks of age. In pigs the coccidia attack
the intestinal mucosa carrying out their life cy-
cle in or just beneath the mucosal epithelium.
Their presence causes destruction of the
villous epithelium resulting in a malabsorptive
diarrhea or in some cases a protein-losing
enteropathy. A recently discovered pathogen
of neonatal calves is the protozoan, Cryto-
sporidia. This organism has a life cycle very
similar to that of the Coccidia spp. but lives on
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the luminal side of the villous epithelial cells.
In its attachment to the cells it displaces the
microvilli of the brush border, leaving a crater
devoid of microvilli when it detaches. The
mechanism of diarrhea production is felt to be
the physical displacement of microvilli, with
the ultimate loss of digestive enzymes and ab-
sorptive surface area.
PATHOPHYSIOLOGY
The mechanisms by which the pathogens
produce disease vary significantly but the
systemic derangements which ultimately
result in the animals death are very similar.
The cause of death in a diarrheic animal is
usually dehydration and cardiovascualr col-
lapse. Acidosis, hyperkalemia and hypoglyce-
mia are commonly observed. Acidosis is the
result of several factors. Lactic acidosis is a
result of anaerobic glycolysis in the tissues of
the animal, caused in part by the poor
tissue perfusion. Sodium-hydrogen exchange
mechanims present in the intestine and the
kidney are affected either directly by the toxins
or destruction of the cells in the intestine or in-
directly by the decreased perfusion of the
kidney due to dehydration.
Hyperkalemia is a secondary effect of the
acidosis. The high concentration of hydrogen
ions in the extracellular fluid causes hydrogen
to diffuse into the cells forcing the potassiU1TI
ions out. A concurrent decrease of intracel-
lular potassium has been documented in di-
arrheic calves with hyperkalemia. 19,20 Calcula-
tions of total body potassium levels show that
an actual loss of potassium occurs in diarrhea
even though the animals present as hy-
perkalemic. The potassiunl iinbalance inhibits
cellular repolarization thereby causing
muscular weakness, paresis and eventually
failure of the cardiac muscles. The
hypoglycemia which occurs with diarrhea may
be due in a large part to the lack of absorption
of glucose from the damaged intestine. The
actual limitation may come in the digestion of
lactose into absorbable monosaccharides. In
the terminal stages of diarrhea a failure of
gluconeogenesis occurs; glycogenolysis helps
to maintain plasma glucose levels for a brief
period but severe hypoglycemia develops and
the animal becomes moribundl9 ,20 The
ultimate demise of the animal is the car-
diovascular collapse resulting from the
hypovolemia and potassium imbalance.
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The specific mechanisms of each pathogen
need to be considered when determining the
probable effectiveness of any form of therapy.
The first pathogens to be considered are the
viruses. Since rotavirus and coronavirus are
the most important viral pathogens en-
countered in neonatal diarrhea, they will be
the only ones considered here. The
pathophysiology of the diseases caused by
these organisn1s is essentially the same, with
the important difference being the location of
their attack on the mucosal epithelium. Cor-
onavirus of swine (TGE) attacks almost ex-
clusively the villous epithelium of the small in-
testine, while the coronavirus of calves may be
found in the superficial and crypt eipthelium of
the spiral colon as well as the small intestine.
The rotaviruses are more selective and attack
only the most mature epithelial cell on the
distal one-third to one-half of the villus. This
difference is important because of the function
of the crypt and villous epithelial cells. The
mature villous cells carry out the digestive and
absorptive functions of the small intestinal
tract while the immature crypt cells are
primarily secretory in function. Rotaviral in-
fections leave a considerable amount of ab-
sorptive epithelium intact allowing for
significant absorption of nutrients and fluid
even though the absorption may not balance
the secretion and diarrhea is occurring. Cor-
onavirus in pigs destroys the entire absorptive
portion of the mucosa leaving only the im-
mature" secretory crypt cells functional. The
destruction of the villous epithelial cells results
in the loss of the digestive enzymes contained
in the brush border along with the absorptive
function of these cells. This causes two
mechanisnls of diarrhea to COine into play, the
first being a simple malabsorption of fluid and
nutrients due to the lack of functional absorp-
tive cells. The second mechanism is a result of
the maldigestion which occurs due to the loss of
digestive enzymes present in the brush border
of the now-destroyed villous epithelium. The
maldigestion leaves a hypertonic solution of
complex carbohydrates and proteins in the
lumen of the intestine. Unless the nutrients are
broken down into simple sugars and peptides
they are unabsorbable. The presence of unab-
sorbable solutes in the lumen results in an
effective osomotic pressure which will cause
water movement from the tissues into the
lumen of the intestine. Thus, not only is the
animal unable to absorb ingested nutrients,
Iowa State Veterinarian
water and ions, but in addition, fluid is being
drawn out of its tissue by osmotic forces. The
loss of absorptive cells from the small intestine
not only causes a malabsorption of water and
nutrients but also destroys part of the
mechanism which maintains the acid-base
balance in the body. The resultant acidosis is a
common factor in neonatal diarrhea as
described above.
Any other organism which disrupts the in-
tegrity of the mucosal epithelium acts by the
same pathophysiological mechanisms as those
described for the viruses. The severity of the
lesion is directly related to the severity of the
resulting disease and inversely related to the
effectiveness of many therapeutic measures.
Many of the bacterial agents as well as some of
the protozoa cause damage to the mucosal
epithelium as part of their pathogenesis, either
through mechanical invasion or through the
elaboration of necrotizing toxins. Malabsorp-
tion and maldigestion are only part of the
problem caused in these cases. Disruption of
cell-to-cell junctions and denuding of areas of
submucosa causes alterations in the
permeability of the mucosal epithelium
resulting in uncontrolled leakage of water and
ions into the intestinal lumen. "Holes" in the
epithelium may become so large as to allow
proteins and even blood to enter the intestinal
lumen. In some cases, such as salmonellosis
and coccidiosis, these lesions are localized,
thereby leaving some areas of intact mucosa
which may allow the animal to absorb some of
the fluid and nutrients from the lumen. If the
lesions are too extensive, however, a disrup-
tion of hydrostatic and oncotic forces may oc-
cur creating a pressure-induced secretion and
preventing any absoption. The specific
mechanisms of these organisms will not be
discussed here.
The group of organisms which differ
drastically in their mechanism of disease pro-
duction are the enterotoxin-producing
bacteria. The most prominent and well
studied member of this group are the
enterotoxigenic E. coli (ETEC). These
organisms produce disease without causing
any mechanical damage to the mucosal epithe-
lium. They act entirely by altering the
metabolic functions of the cells. The first step
necessary for disease production by ETEC is
the establishment of a population in the mam-
malian small intestine. Several host resistance
factors must first be overcome. Upon entering
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the digestive tract of a mammal the bacteria
quickly encounter the gastric barrier. The
high acidity and digestive juices present in the
stomach prove to be very effective in reducing
the number of bacteria which reach the in-
testine in a viable state. Unfortunately this
barrier is poorly developed in the neonates
making them more susceptible to bacterial in-
vasion into the intestinal tract.
The next host factor which the bacteria must
overcome is the intestinal motility and the flow
of ingesta through the intestinal lumen. Many
pathogenic strains of E. coli have developed
surface structures, known as pili, which allow
them to attach to the mucosal surface and re-
sist being swept along with the other luminal
contents. This adaptation allows the bacteria
to remain in the small intestine long enough to
proliferate and produce toxins. It also provides
a series of antigens which are helpful in pro-
ducing immunity against infection.
Three different enterotoxins have been
found to be produced by various strains of
ETEC. One, a heat labile toxin (LT), has a high
molecular weight and a structure and
mechanism of action similar to cholera toxin.
The other two toxins are low molecular weight
proteins and are heat stable (ST). One of the
stable toxins, STa , is soluble in methanol
while the other, STb , is methanol-insoluble.
Along with their differences in physical prop-
erties comes a difference in their biological ac-
tivity. STa has been found to be active in the
neonatal pig and detectable by the suckling
mouse assay, while STb is active in weaned
pigs and not in the suckling mouse. Strains of
ETEC isolated from calves appear to produce
only STa and not STb or LT.
All of the enterotoxins act by altering the ion
transport mechanisms of the mucosal epi-
thelial cells without causing any histological
damage to the cells. LT stimulates the adenyl
cyclase system causing the increased produc-
tion of cyclic AMP. The cAMP mediates in-
testinal secretion by rearranging sodium and
chloride transport mechanisn1s in the epi-
thelial cels. In contrast, both STa and STb act
by stimulating guanylate cyclase, producing
increased levels of cyclic G MP without affec-
ting the cAMP lvels. Cyclic GMP acts pri-
marily by inhibiting the absorptive
mechanisms, while cAMP stimulates secretion
as well as inhibiting absorption. Both result in
net secretion into the intestinal lumen. A
diagrammatic summary of the cellular mecha-
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Fig. 2. Postulated intracellular control mechanisms
regulating small intestinal ion transport. Stimulation
is indicated by a plus and inhibition by a minus. ST,
heat-stable E. coli enterotoxin; P-kinases, protein
kinases; CDR, calcium-dependent regulator protein or
calmodulin; CaRes, calcium reservoir; LT, heat-labile
v. cholerae or E. coli entertoxin; BS, bile salts; FA, Fat-
ty acids; VIP, Vasoactive intestinal peptide; PG, pro-
staglandins; ACh, acetylcholine; 5-HT, serotonin;
Otadren., a-adrenergic agonist. Net secretion is thought
to involve two separate alterations of luminal (brush-
border) membrane permeability: inhibition of NaCI
cotransport and an increase in CI- conductance.
Although depicted in the same cell, these 2 effects may
occur in separate cells. Both may occur in response to
P-kinase activation, CDR activation, or an increase in
cytosolic free Ca. Relative contributions of these .)
effectors to the above 2 permeability changes are not
known. Calcium-mediated secretion may occur as a
result of ACh- or 5-HT-mediated increases in Ca-
gating or cAMP-mediated release of reservoir Ca. Ac-
cording to work with isolated pancreatic islets (24,
142, 218), a-adrenergic agonists may inhibit secretion
by blocking Ca2+ entry. Cyclic AMP-mediated secre-
tion may occur as a result of basolateral membrane
adenylate cyclase stimulation by L T, BAS, FA, VIP,
or PG or by cAMP phosphodiesterase inhibition (not
shown). Cyclic GMP-mediated secretion can occur in
response to ST stimulation of brush-border guanylate
cyclase. [Powell, Secretory Diarrhea, 1980.]
nisms affected by the toxins is presented in Fig.
2. 21
Toxin effects are not limited to the small in-
testinal mucosa. It is likely that a normally-
functioning colon would be capable of com-
pensating for the additional secretion which
occurs in the small intestine under the influ-
ence of enterotoxins. However, the toxin-
producing E. coli are present in the colon as
well and the enterotoxins have been shown to
inhibit normal colonic function. 3 Thus it
seems that the compensating mechanisms of
the colon may be impaired.
Enterotoxins produced by ETEC do not di-
rectIy affect the digestion of disaccharides or
the absorption of glucose and amino acids by
the small intestinal mucosa, nor the coupling
of sodium absorption to these mechanisms.
However the total amount of glucose absorbed
may be affected by the decreased transit time
due to the hypermotility of the gut and also the
decreased intake of lllilk by the weakened calf
or pig. The profound dehydration and elec-
trolyte imbalances described above occur in
colibacillosis as well. The untreated animal
will eventually die from cardiovascular
collapse.
APPROACH TO THERAPY:
Chemotherapy
1) Immunity
The first logical step in the treatment of
neonatal diarrhea is the prevention of infec-
tion. Immunity provides a natural defense
mechanism and enhancement of this mecha-
nism is the goal ofmany preventative medicine
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programs. It is, for the most part, a function of
the dam since the neonates usually do not have
time to develop active immunity before they
are challenged by pathogens. Vaccination or
exposure of the dam to expected pathogens in-
creases the amount of antibodies which are
then secreted in the colostrum. Some species
transfer antibodies transplacentally, but this is
not true of swine or cattle. Therefore ingestion
of colostrum is of utmost importance, because
without it the newborn calf or pig is totally un-
protected until its own immunity develops in
two to three weeks. In the case of viral infec-
tions vaccination of the dam may be the only
effective treatment. Vaccination against pilus
antigens provides additional defense against
colibacillosis.
2) Antimicrobial and Antiviral Agents
Once infection has occurred the use of
chemical agents directed against the invading
organism seems to be the defense action
prefered by many. This mayor may not be an
effective plan. In the case of viral infections,
there is no effective antiviral agent available
for use in animals. This is reasonable consider-
ing that viruses are intracellular organisms us-
ing normal cellular mechanisms for their
replication. Finding an agent which is toxic to
a virus and not to a mammalian cell is a con-
siderable challenge.
Antibacterial agents present a different pic-
ture. A multitude of antibacterial agents are
available for use with an endless variety of
specific actions and side effects. Antibiotics
were discovered by man many years ago but
they have been in existence longer than man
himself. Fungi and bacteria have engaged in
chemical warfare for ages. The chemical tox-
ins produced by fungi against bacteria have
been met by a continually changing set of
resistance factors developed by the bacteria.
This ability to develop means to resist destruc-
tion is just as effective against antibacterial
agents produced by man as it is against those
elaborated by the fungi. The result of this is the
antibiotic resistance which is encountered in
both veterinary and human medicine. This
resistance has been used as an argument
against the use of antibiotics in many situa-
tions. Some fear that if the heavy use of an-
tibiotics in veterinary medicine continues a
super-resistant bacteria may soon develop and
an infection of the human population would be
uncontrollable and devastating. As a result of
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this resistance development many of the drugs
which were effective a few years ago no longer
seem to have an impact. 26 Some studies have
shown greater than ninety percent resistance
to commonly used antibiotics by field strains of
pathogenic E. coli. 19.20 In many cases the drugs
which are most effective are not approved for
use in food animals. Pharmaceutical com-
panies are making some progress in the
development of synthetic antimicrobials which
are resistant to many of the known microbial
resistance factors. 27 However, there is no
reason to believe that the bacteria won't even-
tually find a way to resist these agents as well.
Besides the problem of resistance, some an-
timicrobial agents have been shown to cause
damage to the intestinal mucosa and may ac-
tually exacerbate the disease they are supposed
to control. 19,20 In light of all the conflicting
evidence involving antibiotic therapy for di-
arrheal diseases careful consideration should
be given to the choice of antibiotics and even as
to whether or not they are indicated at all in a
particular case.
3) Antitoxins
Specific antitoxins are available for a num-
ber of toxin-produced diseases, tetanus being
the most well known. Enteric antitoxins are
not as common. Clostridium perfringens) cholera
and heat labile E. coli toxins are about the only
toxins which are conducive to antitoxin pro-
duction. The E. coli ST's are too small to be an-
tigenic without first binding them to carrier
proteins. The use of specific antitoxins in diar-
rhea is of questionable value. While they ap-
pear to be very effective, occasional "breaks"
occur in spite of regular use. Also injectable
antitoxin might not be of use against the toxins
which primarily affect the luminal membrane
ofmucosal epithelial cells and are not absorbed
into the body.
Nonspecific antitoxins exist but are of
dubious value. Activated charcoal, kaolin and
various clays have been used, charcoal being
the most effective of these. Bisumth sub-
salicylate, a besides having some antitoxic
properties also has some antibacterial and
possibly antiinflammatory effects. Resins may
be more effective than nonspecific adsorbants.
In vitro) cholestyramine is significantly more
effective than kaolin in binding toxins. This
apeptobismol, Norwich-Eaton Pharmaceuticals, Nor-
wich, New York.
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effect is also present in vivo, but is is markedly
decreased by the presence of milk. 12 Cost effec-
tiveness of any enteric antitoxin is ques-
tionable, but specific antitoxins show con-
siderably more promise than do nonspecific,
adsorbant-type compounds.
4) Cell Metabolism Moderators
Since many of the pathogens cause diarrhea
by affecting the cellular metabolic processes in
the mucosal epithelium, a logical approach to
the control of diarrhea is through control of
these mechanisms. So far no major break-
throughs have come in this area although con-
siderable research is being done. A number of
products have been somewhat effective in con-
trolling diarrhea but there is a need to deter-
llline the lllechanislll of action of these agents,
their side effects and contraindications.
Nicotinic acid is one compound found to be at
least partially effective in controlling secretory
diarrhea. It acts by inhibiting the adenyl
cyclase activity, the mechanism which is
stimulated by LT and cholera toxin. Chlor-
promazine and melperone are two compounds
which act by blocking calmodulin (CDR), a
calcium-dependent regulatory protein which
controls cellular secretion among several
cellular metabolic functions.
Anticholinergics are a group of compounds
which were originally used in treatment of
diarrhea because of their effect on gut motility.
I t has since been determined that they also
effect intestinal absorption by actively decreas-
ing the secretory component of the diarrhea.
Unfortunately this antisecretory action also
affects the gastric mucosa, decreasing the
gastric secretion and with it the effectiveness of
the gastric barrier to intestinal invasion.
Although they are still used primarily for their
antiperistaltic activity, the antisecretory prop-
erties of these drugs may prove to be helpful in
determining cellular mechanisms and control
of diarrhea.
Acidic antiinflammatory agents are the
most recent group of drugs to come into use in
the treatment of diarrhea. These compounds
act by inhibiting prostaglandins. Prostaglan-
dins are known to playa role in the absorptive
and secretory mechanisms of the gastrointes-
tinal tract as well as a number of other cellular
mechanisms throughout the body. Aspirin, in-
domethacin and 5-aminosalicyclic acid are a
few of the acidic antiinflammatory agents
under study. Unfortunately these agents have
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been only marginally effective and because of
the involvement of prostaglandins in body
metabolic functions, many side effects are
possible with their use. The search continues
for drugs which are specific for the G I tract in
their mechanism of action. So far no cellular
mechanism mediator exclusive to the gut has
been determined, making the control of diar-
rhea without other effects very diffiicult.
5) Antispasmodics and Motility Control
The role of motility in diarrhea has been ex-
amined for many years. It was believed for a
long period that hypermotility was actually the
cause of diarrhea and that if the transit time
was increased the diarrhea would be cured.
The search for motility-controlling agents led
to the use of anticholinergics, opiates and mor-
phine derivatives in the treatment of diarrhea.
These drugs proved to be clinically very effec-
tive in some cases, useless in others. It has
since been determined that diarrhea may be
present with not only hypermotility but also
with hypomotility and normal motility. It ap-
pears now as though motility changes are not
the cause of the diarrhea but rather a reaction
of the gut to the pathogens which are present.
It may, in fact, be a protective mechanism. A
secretory type of diarrhea, such as colibacillo-
sis, is often associated with hypermotility,
while a malabsorptive type of diarrhea, such as
TGE, is commonly associated with hypo-
motility or normal motility. Teleological
speculation is the only explanation for this at
present, suggesting that in the presence of a
toxin the body is attempting to rid iself of the
offending organism and its toxin, while in a
malabsorptive situation the gut may actually
try to retain material so that the few remaining
functional cells have an increased opportunity
to absorb water and nutrients from this ma-
terial. This is, of course, only speculation, but
it does help in pointing out a few of the con-
traindications to this method of treatment.
First, if hypermotility only occurs in some
cases of diarrhea, how does one arrive at the
decision to use an antispasmodic agent? If the
gut happened to be hypomotile an antichol-
inergic would only exacerbate the situation.
Next, controlling motility does little or nothing
to stop secretion. The fluid loss into the in-
testine is still occurring. The animal is still go-
ing to die from dehydration even though
clinically the diarrhea has improved. The
animal derives no benefit from this treatment
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and in fact may be suffering from it. As men-
tioned earlier, scouring may in itself be a pro-
tective mechanism, eliminating toxins and
organisms by propelling them out of the body.
Decreasing the motility will result in all of the
fluid, toxins and rapidly proliferating bacteria
pooling inside the animal's gut. Another se-
quela to this treatment is the misinterpretation
of the disease state of the animal and prema-
ture cessation of supportive therapy. If the
amount of fluid loss is determined by the
amount of fluid feces present, replacement
therapy will be grossly inadequate. Although
the antispasmodics have been empirically
effective, they offer very little benefit to the
animal and may present considerable risk
under certain condtions.
Two major drug groups are used to control
the transit of ingesta through the intestinal
tract. The anticholinergics act to decrease
peristalsis and are used primarily for this pur-
pose although they also seem to have some
effect on the secretory mechanisms of diar-
rhea. These drugs were discussed briefly
above. The other major group is the opiates
and morphine derivatives, such as lopera-
mide. These drugs act on the gut by increasing
the segmental contractions. Some of them may
also decrease peristalsis slightly. The major
purpose of using these drugs is to increase in-
gesta transit time without halting peristalsis.
These drugs also have effects on the absorptive
and secretory functions of the mucosal
epithelium that are not fully understood.
Although they are not used much in veterinary
medicine they have been employed extensively
in the control of human diarrhea.
Fluid Therapy
The major goals of fluid therapy are to
replace the fluid losses, correct electrolyte im-
balances and provide energy and nutrients to
the disabled animal. The first step in fluid
therapy is the assessment of the needs of the
animal. The needs include not only the fluid
which has already been lost, current dehydra-
tion, but also continuing fluid losses through
diarrhea, maintenance requirements and elec-
trolyte imbalances . Dehydration is best
estimated on the basis of clinical signs such as
skin tension, sunken eyes and dry mucous
membranes. A table of these signs and the
level of dehydration they indicate is included
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in Figure 3. Laboratory parameters are not
very useful in determining the initial state of
dehydration because of the wide variation
among norrnal neonates. :tvfonitoring changes
in the lab data may be useful in determining
progress during therapy. The volume of re-
placement fluids can be calculated from the
weight of the animal and the estimated deficit.
Determination of the electrolyte imbalances
comes from a knowledge of ,the
pathophysiology of the disease. This aspect
was discussed above. Clinical signs of some of
the imbalances include rapid respiration in
response to acidosis, weakness or general
paresis due to the potassium imbalance and
hypoglycemic coma. All of these needs should
be taken into account when instituting fluid
therapy.
The next decision is the route of administra-
tion. Subcutaneous fluid therapy is fast and
simple but rather ineffective in a severely
dehydrated animal. Perfusion of the peri-
pheral parts of the body is generally very poor,
resulting in poor absorption of the fluids. The
volume of fluids which may be given by this
n1ethod is limited and may be inadequate. The
next possibility is intraperitoneally. This
choice presents the risk of causing peritonitis
and the amount of uptake by this route is ques-
tionable. The best route in the severely dehy-
drated animal, greater than six percent, is in-
travenous. Although this route requires con-
siderable care in administration with regard to
cleanliness and technique, it offers the best ad-
vantage in getting the proper volume of fluid
and electrolytes to the area where they are
needed most. Intravenous therapy, while
medically the best choice, may be economical-
ly prohibitive. This is especially true when
dealing with a major herd problem or with
pigs. Oral fluid therapy seems to be the
method of choice when dealing with a large
number of individuals which require treat-
ment or when the value of an animal does not
warrant the expense involved in intravenous
therapy. This is the most economical and
effective method of treatment early in the
disease. Dry mixes of glucose and electrolytes
can be added to the drinking water and the
animals can "self treat" as they drink. The need
for sterility is eliminated and the treatment can
be administered by the owner rather than the
veterinarian. There are contraindications for
oral therapy however. One is the moribund
animal in which oral therapy is simply too slow
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Percentage body
weight loss
6% -8 %
Clinical signs
1. Mild depression
2. Decreased urine output
1. Sunken eye
2. Tight skin
3. Depressed but standing
4. Dry mouth/nose
5. Further urine reduction
1. Increase in above
2. Cold extremities
3. Recurnbancy
1. Shock
2. Death
Fig. 3. Degree of dehydration-clinical signs.
to save the animal. The other is malabsorptive
diarrhea. Consider TGE as an example. If a
glucose-electrolyte solution is placed in the gut
of an affected pig the glucose and ions would be
unabsorbable. Their presence in the lumen
would cause water movement out of the tissues
and into the lumen in an attempt to equalize
the concentrations. Thus, instead of replacing
fluid the effect would be an increased loss and
accelerated demise of the animal. It is partly
because of this that a diagnosis is needed to
determine effective therapy. If, as in the case of
rotavirus, some of the absorptive cells are still
functional oral therapy may be of some use in
treatment.
Composition of the fluids must be given
some consideration. The exact makeup of the
glucose-electrolyte solution is disagreed on by
several researchers. The presence of certain
elements is necessary however. A solution
should contain sodiulll, potassium, chloride,
some form of base and glucose. Approximately
150 meq/l of sodium should be present. Potas-
sium concentrations may vary from 5 to 35
meq/l without adverse effects. The base may
be in the form of bicarbonate, citrate or lac-
tate. Some feel that bicarbonate is detrimental
in oral therapy because it tends to increase
gastric pH. 7 Others state that citrate and lac-
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tate are of limited usefulness because they
must be metabolized in the body before they
contribute to the resolution of the acidosis. 19,20
Bicarbonate is also a readily available com-
pound for use in home mixtures, more so than
the other two. The amount of glucose in the
solution is a point of considerable controversy.
It brings into consideration the question of
tonicity as well as that of energy requirements.
Although simple saline is helpful in restor-
ing fluid losses of the animal, the need for the
other components of the solutions is clear from
the pathophysiology. The use of bicarbonate
or some other base neutralizes the extracel-
lular hydrogen ions. This allows more hydro-
gen ions to leave the cells and drives the
potassium back into the cells. By this means
the bicarbonate helps relieve the hyperkalemia
as well as the acidosis. Glucose also aids in the
resolution of the hyperkalemia by stimulating
the release of insulin which will drive the
potassium back into the cell. Even though a
hyperkalemia exists there is actually a loss of
potassium in diarrhea. For this reason,
potassium must be added to the solution.
Osmolarity is an important point to be con-
sidered when preparing a solution for therapy
purposes. The controversy in this matter oc-
curs primarily in regard to oral therapy. The
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osmolarity of intravenous solutions is of little
concern if care is taken in their administration.
Some investigators contend that a solution for
oral therapy should be isotonic. They feel that
a hypertonic solution would osmotically in-
duce secretion. 7 This is only true if the com-
ponents of the solution are unabsorable. With
the exception ofmalabsorptive-type diarrheas,
the transport of glucose and electrolytes across
the mucosal epithelium is unimpaired. Since
the glucose is readily absorbed it cannot con-
tribute to osmotic forces which would draw
water out of the tissues and into the lumen.
Recent studies have shown that the osmolarity
of a solution is actually increased before it
leaves the stomach and the use of isotonic or
hypotonic solutions increases gastric emptying
time. 19 ,2o
The controversy over tonicity of therapy
solutions could be easily solved by simply mak-
ing them all isotonic since this does not present
any particularly harmful possibilities. The
osmolarity of the solutions is largely deter-
mined by the amount of glucose in the solu-
tions, and this on initial examination would
seem to be expendable. The purpose of the
glucose in the solutions is twofold, however.
Glucose enhances the absorption of water and
electrolytes from the lumen and it also pro-
vides energy for the debilitated animal. It is
the second purpose which drastically increases
the need for high levels of glucose in the solu-
tions. Isotonic solutions do not contain more
than a fraction of the energy required by a
diarrheic animal. If the energy requirements
of the animal are not at least partially met the
animal may die from starvation or be per-
manently stunted upon recovery. Studies have
shown that diarrheic calves do better during
and after treatment if high levels of glucose are
added to the solutions. 19,20 The use of in-
travenous glucose as an adjunct to oral therapy
is very helpful.
In addition to adding glucose to therapeutic
solutions to meet energy requirements, some
investigators propose that actual hyperalimen-
tation may be the best therapy. Addition of
amino acids to glucose and electrolyte solu -
tions would provide the animal with all of the
basic elements to sustain life during its illness.
While this treatment does offer additional ad-
vantage to the diarrheic animal it also causes a
tremendous increase in the cost of therapy.
Even though this should be kept in mind as an
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option on a highly valuable animal, it is prob-
ably cost-prohibitive for routine use.
Other Considerations
A few other possibilities exist for the treat-
ment or prevention of diarrhea. For the most
part they are not heavily studied procedures
and little hard evidence is available in their
support. They are, however, things which
may see more use as the understanding of the
mechanisms of diarrhea increases.
The first is the use of "biological warfare"
within the intestine of the neonate. This in-
volves innoculating newborn animals with
nonpathogenic bacteria in the hopes of
discouraging colonization by pathogens
through competition. Some of the bacteria
available for this purpose are believed to have
some antipathogenic properties. The in-
noculation of baby pigs \vith cultures of Lac-
tobacillus falls into this category.
A procedure which is as yet untried but
similar to the one discussed above is actually
an attempt to create "age resistance factors" in
baby pigs against TGE. While TGE infects all
ages of swine it is only the neonates which die
from the disease. This may in part be due to
their inability to utilize any of the nutrients
which pass through their diseased intestine. In
the older pigs the carbohydrates in the un-
digested milk are fermented in the colon by
lactose-fermenting bacteria. The resulting
volatile fatty acids are readily absorbed by the
colon along with a considerable amount of
water. It is conceivable that if the baby pigs
were innoculated with a culture of non-
pathogenic lactose-fern1enting bacteria they
may have a better chance of surviving the
disease. Although it is little more than specula-
tion at this point it is worth some considera-
tion.
One element ofanimal disease which cannot
be ignored is management. No amount of
therapeutic drugs or fluids will overcome the
effects of poor hygiene and sloppy manage-
ment of the animals. Prevention of disease is
always more effective than cures. Even though
additional cost may be incurred by instituting
a proper management program, this cost may
eventually be recovered in decreased losses
from disease.
CONCLUSION
There is much to be learned about the con-
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trol of diarrhea in neonatal animals. Progress
is slow but it is important for the practitioner
to keep in touch with the latest information
and to utilize that information for the benefit of
his patients and clients. Empirical treatment of
disease is no longer a cost effective procedure;
if it was the local feed supplier would probably
put the veterinarian out of business. The vet-
erinarian must utilize all of his knowledge and
training in determining the best treatment for
his patients.
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